The place of cardiac glycosides in the treatment of chronic heart failure. Part III. The DIG trial

Kardiologiya

Volumn 45, Issue 6, 2005, Pages 61-70

  Sidorenko, B A ^a   Preobrazhensky, D V ^a   Sharoshina, I A ^a   Batyraliev, T A ^a   Pershukov, I V ^a   Mahmuthodzhaev, S A ^a  

^a NONE

Author keywords

Digoxin; Heart failure, treatment, mortality

Indexed keywords

CARDIAC GLYCOSIDE; CARDIOTONIC AGENT;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

CARDIAC GLYCOSIDES; CARDIOTONIC AGENTS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL CONTRACTION; RANDOMIZED CONTROLLED TRIALS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 33645059246     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)